期刊文献+

猪瘟DNA疫苗制备工艺研究 被引量:2

Study on Preparative Protocol of DNA Vaccine Against Classical Swine Fever
下载PDF
导出
摘要 猪瘟DNA疫苗制备工艺的建立是其走向产业化 ,从而在猪瘟防制中发挥作用所需解决的关键问题之一。以猪瘟DNA疫苗质粒pVAXE2IL2转化大肠杆菌后 ,转入发酵罐发酵培养。将菌体悬浮裂解和中和后 ,经澄清和浓缩处理 ,上阴离子交换色谱和体积排阻色谱进行纯化 ,首次提纯出符合药学规格的猪瘟DNA疫苗 ,且整个工艺回收率达 64 5 3% 。 DNA immunization is one of the stratigies in control of classic swine fever (CSF),a viral disease. Here we reported a chromotagraphy_based technology in production of DNA vaccine plasmid with high yield and purity.The experimental DNA vaccine encoding CSFV E2 protein and IL_2 in one plasmid was amplified in Escherichia coli strain of DH5α. After fermentation in complex medium the plasmid DNA was pre_processed and purified first with anion exchange chromatography followed by size exclusion chromatography. The final results showed that the quality of purified plasmid DNA met the standards for preparation of pharmaceutical grade plasmid DNA.
出处 《中国生物工程杂志》 CAS CSCD 2004年第10期63-69,共7页 China Biotechnology
基金 国家"8 63"计划资助项目 (2 0 0 4AA2 13 10 1)
关键词 DNA疫苗 首次 药学 大肠 阴离子交换色谱 制备工艺 质粒 猪瘟 防制 发酵培养 Classical swine fever DNA vaccine Chromatography preparation Quality control
  • 相关文献

参考文献10

  • 1Yu X,Tu C,Li H,et al. DNA-mediated protection against classical swine fever virus. Vaccine,2001,19( 11 - 12):1520 - 1525
  • 2Ferreira GN, Monteiro GA, Prazeres DM, et al. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotechnol,2000,18(9) :380 - 388
  • 3Varley DL, Hitchcock AG, Weiss AME, et al. Production of plasmid DNA for human gene therapy using modified alkaline cell lysis and expanded bed anion exchange chromatography. Bioseparation, 1999,8:209 - 217
  • 4Kostal J, Mulchandani A, Chen W. Affinity purification of plasmid DNA by temperature-triggered precipitation. Biotechnology and Bioengineering, 2004,85 (3): 293 - 297
  • 5Schleef M, Schmidt T. Animal-free production of ccc-supercoiled plasmids for research and clinical applications. The Journal of Gene Medicine, 2004,6: S45 - S53
  • 6Ferreira GNM, Monteiro GA, Prazeres DMF, et al. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotech,2000, (18) :380 - 388
  • 7Durlans RH, Eastman EM. Manufacturing and quality control of plasmid-based gene expression systems. Advance Drug Delivery Reviews, 1998,30( 1 - 3): 33 - 48
  • 8Horn NA, Meek JA, Budahazi G, et al. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials.Human Gene Therapy, 1995, (6) :565 - 573
  • 9JSambrook DWRusell(黄培堂 译).分子克隆实验指南(第三版)[M].北京:科学出版社,2002..
  • 10林懿,陈祖欢,郭瀛军,孙树汉.高密度培养大肠杆菌生产重组钩端螺旋体DNA疫苗[J].第二军医大学学报,2002,23(8):828-829. 被引量:5

二级参考文献4

共引文献5

同被引文献23

  • 1呼西旦,蔡宏,李淑霞,田霞,朱玉贤.Ag85B核酸疫苗的免疫原性和保护性研究[J].中国人兽共患病杂志,2004,20(5):365-368. 被引量:7
  • 2余大海,蔡宏,朱玉贤.佐剂DDA和MPL对提高结核杆菌组合DNA疫苗免疫效果的比较研究[J].生物化学与生物物理进展,2005,32(8):765-770. 被引量:7
  • 3余大海,田霞,蔡宏,朱玉贤.DDA提高结核杆菌组合DNA疫苗免疫效果的研究[J].高技术通讯,2006,16(2):171-174. 被引量:2
  • 4张万江,邓喜玲,吴芳,黄春,曹旭东,吴江东,杜燕,李蕾.结核杆菌Ag85B基因疫苗的免疫保护效果研究[J].生命科学研究,2006,10(2):128-133. 被引量:3
  • 5萨姆布鲁克J,拉塞尔D W,黄培堂,王嘉玺,朱厚础,等译.分子克隆实验指南[M]3版.北京:科学出版社,2002..
  • 6BUDDLE B M,SKINNER M A,WEDLOCK D N,et al. New generation vaccines and delivery systems for control of bovine tuberculosis in cattle and wildlife[J]. Vet Irnmunol Immuno patho1,2002,87(3/4) : 177 185.
  • 7AGGER E M, ANDERSEN P. Tuberculosis subunit vaccine development : on the role of interferon-[J]. Vaccine, 2001,19 (17/19) :2298-2302.
  • 8BELISLE J T, VISSA V D, SIEVERT T, et al. Role of the major antigen of Mycobacterium tuberculosis in cell wall bio- genesi[J]. Science,1997,276(5317) :1420-1422.
  • 9RONNING D R, KLABUNDE T, BESRA G S, et al. Crystal structure of the secreted form of antigen 85C reveal potential targets for mycobacteriaI drugs and vaccines[J]. Nat Struct Bio1,2000,7(2) :141 146.
  • 10NAKAMURA R M, EINCK L, VELMONTE M A, et al. De- tection of active tuberculosis by an MPB-64 transdermal patcha field study[J]. Stand J Infect Dis ,2001,33(6) :405 407.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部